Pearls and Pitfalls in Factor Inhibitor Testing
|
|
- Ginger Stokes
- 6 years ago
- Views:
Transcription
1 Pearls and Pitfalls in Factor Inhibitor Testing Dorothy M. Adcock M.D. Esoterix Coagulation, Laboratory Corporation of America Holdings ISLH May 19, 2015
2 Outline Overview of coagulation factor inhibitors Review of the incubated mixing test Review of the Bethesda assay and Nijmegen modification Example cases Potential causes of false positive and false negative factor inhibitor assays Safeguards in testing
3 Coagulation Factor Inhibitors Polyclonal immunoglobulins that bind and neutralize the activity of a coagulation factor Not all antibodies are functional neutralizers Develop in patients with congenital factor deficiency in response to replacement therapy or as an autoimmune phenomenon Can be life-threatening and/or lead to significant morbidity False positive and negative results can lead to serious patient mismanagement Proficiency testing surveys* reveal 32% false positive and 5% false negative results; with no improvement over the past decade *ECAT, NEQAS, RCPA QAP
4 Assays to Detect and Measure Coagulation Factor Inhibitors 1959: Oxford Assay; considered unreliable Uses Cryoprecipitate as the FVIII source 1975: Bethesda assay; allowed an acceptable degree of standardization but considered rather non-specific * (many false positive results) Uses NPP as FVIII source Uses NPP + imidazole buffer as reference 1995: Nijmegen assay; decreases false-low positive results Uses buffered NPP Replaces imidizole with FVIII deficient plasma * Hemophilia 2014, 20 (Suppl.4), 94-98
5 Normal Plasma Mixing Test Factor inhibitor assays [Bethesda assay (BA)/Nijmegan (NBA] are based on a normal plasma mixing test Causes These are of an the abnormal very same mixing causes test of (lack a of correction false positive into BA/NBA the normal reference interval): Factor inhibitor* Lupus anticoagulant* EDTA plasma* Direct Oral Anticoagulants (DOACs)* Heparin *May demonstrate prolongation with incubation
6 Incubated Mixing Test 50% 50% Incubate each at 37 C for 60 to 120 minutes, then mix patient with NPP Patient NPP Patient + NPP Compare Incubated Mix to Control Separately incubated patient + NPP Mix (Control) Patient + NPP Incubated together (Incubated Mix)
7 Sample Plasma Mixing Study Table Results in Seconds FVIII Inhibitor Fast Slow FVIII Deficiency Lupus Anticoagulant FIX Inhibitor APTT Normal APTT 1:1 immediate APTT 1:1 Incubated NP Control APTT 1:1 Incubated NP Patient
8 Bethesda Assay (BA) Neat 1:2 1:4 1:8 Patient 37 C Perform Factor Activity 1:10 & 1:20 Patient + NPP Control Determine RA% = Patient Mix Control Buffer + NPP 37 C Perform Factor Activity RA must fall between 25% and 75% to call a result positive and to calculate a titer
9 Determining Bethesda Titer Corrected Percent Residual Factor Activity Bethesda Units Per ml Plasma Graphically or by using Excel Bethesda Unit (BU) = ( 2-log %RA)/ Correct for dilutions if needed! RA must fall between 25% and 75% RA <25%: make additional dilutions RA >75%: BA is negative and this equates to 0.4 BU Internationally agreed upon detection limit 0.6 BU* * Hemophilia 2014, 20 (Suppl.4), 94-98
10 Bethesda Assay Methodology with Nijmegen Modification Neat 1:2 1:4 1:8 Patient Patient + NPP Buffered NPP Control Factor Buffer DP + NPP + NPP Nijmegen modification uses buffered normal plasma in the patient mix and Factor DP (or 4% albumin)* rather than buffer in the control mix Increase in ph leads to inactivation of FVIII and this is further enhanced with reduced protein concentration Nijmegen modification increases specificity and assay reliability *Giles AR, et al. Thromb Haemost 1998;79:872-5
11 BA Calculation Sheet Example Patient Dependent Dilution FVIII Bethesda Assay Calculation Sheet Patient Tube Factor VIII Activity 1:10 1:20 Av Control Tube Factor Activity %RA Log Residual Activity BU BU X dilution factor Smith 1 Vmax Vmax ncalc 45 ncalc ncalc ncalc ncalc 1:2 Vmax Vmax ncalc 45 ncalc ncalc ncalc ncalc 1:5 5.2 Vmax : : : : :
12 Causes of False Positive BAs Perfect mimic a FVIII inhibitor EDTA Plasma Decrease in FVIII activity, lack of correction with 1:1 mix, prolongation with incubation and positive NBA Causes of Positive NBA but with Non- Parallelism Factor inhibitor in a BA other than the assay of involved factor Such as a FVIII inhibitor in a FIX or FXI NBA Lupus anticoagulant Direct oral anticoagulants Heparin
13 Specific Factor Inhibitor Present but is Other than the Factor Inhibitor Under Investigation A strong FVIII inhibitor: Can inhibit the FVIII in a FIX or FXI activity assay causing factor IX or XI to appear spuriously low Appears as a non-specific inhibitor as it can be diluted Can cause a false positive FIX or FXI BA Typical BA results, if run on all intrinsic factors: Bethesda Assay Bethesda Titer Factor VIIII 850 Factor IX 13 Factor XI 18
14 Example: FVIII Inhibitor in a FIX BA FIX Bethesda Assay Calculation Sheet Patient Dependent Dilution Patient Tube Factor IX Activity Control Factor Activity %RA Log Residual Activity BU BU X dilution Factor 1:10 1:20 Av Jones ncalc ncalc ncalc ncalc 1: ncalc ncalc ncalc ncalc 1: *** 53 ncalc ncalc ncalc ncalc 1: *** 53 ncalc ncalc ncalc ncalc 1: *** 53 ncalc ncalc ncalc ncalc 1: *** 53 ncalc ncalc ncalc ncalc ***If non-parallelism occurs, further investigation is needed.
15 Example: FVIII Inhibitor in a FIX BA Activities of Dependent Dilutions Performed at One Dilution Only Patient Dilution Patient Tube Factor IX Activity Factor IX Bethesda Assay Calculation Sheet Control Factor Activity %RA Log Residual Activity BU BU X dilution Factor Jones ncalc* ncalc ncalc 1: ncalc ncalc ncalc 1: : : : Potential for reporting false positive BA result
16 Safeguards in Performing Bethesda Assays Characterize the plasma sample by performing APTT, PT and thrombin time Rule out EDTA Rule out anticoagulant drug effect Properly perform and interpret incubated APTT mixing test and correlate this with results Perform the Nijmegen modification rather than the standard Bethesda assay Perform the dependent dilutions of the NBA at 2 dilutions and investigate non-parallelism
17 Thank you for your attention Dorothy M. Adcock
R.Li, C.Swaelens, F.Vandermijnsbrugge, B.Cantinieaux BSTH Laboratory of haematology, Porte de Hal,
Institut J. Bordet Normal with Actin-FS avoids intrinsic pathway factors assays in the presence of an isolated prolongation of (Platelin-LS) without hemorrhagic history R.Li, C.Swaelens, F.Vandermijnsbrugge,
More informationLaboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation
Laboratory Investigation of Challenging Cases Laura A. Worfolk, Ph.D Scientific Director, Coagulation Coagulation Cascade XII XIIa XI HMWK/Prekallikrein XIa VII Injury IX X IXa VIII Xa X TF TF/VIIa Prothrombin
More informationDOAC s and Implications on Laboratory Results. Kandice Kottke-Marchant, MD, PhD Cleveland Clinic
DOAC s and Implications on Laboratory Results Kandice Kottke-Marchant, MD, PhD Cleveland Clinic Anticoagulants Heparin Low Molecular Weight Heparins enoxaparin, fragmin Heparin pentasaccharide - fondaparinux
More informationLaboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation
Laboratory Investigation of Challenging Cases Laura A. Worfolk, Ph.D Scientific Director, Coagulation Disclosures Employee of Quest Diagnostics Case focus: Importance of knowing test limitation/interpretations
More informationActivated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective?
Activated Protein C Resistance vs Factor V Leiden assay: Which is the most cost effective? Rajiv K. Pruthi, M.B.B.S Co-Director, Special Coagulation Laboratory & Director, Mayo Comprehensive Hemophilia
More informationCurrent laboratory practices in the diagnosis and management of haemophilia
Current laboratory practices in the diagnosis and management of haemophilia Marc Jacquemin University of Leuven BSTH 2013 Detection of severe haemophilia A Validation of the FVIII assay for the detection
More informationSuitability of analytical methods for detection of thrombogenic factor XIa in Privigen
Suitability of analytical methods for detection of thrombogenic factor XIa in Privigen Absence of thrombogenic factors in Privigen M. Moses, K. Ruhwedel, H.-A. Stöhr, L. Duse, A. Feussner, W. Wormsbächer,
More informationLABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY
LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY 1 WHEN IS THE LAB REQUIRED TO INVESTIGATE FOR A POSSIBLE BLEEDING DISORDER? Clinically suspected bleeding tendency
More informationLaboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016
Laboratory investigation in the Bleeding Patient Dr Craig Taylor Consultant Haematologist May 2016 Introduction Bleeding is common May consume significant resources Crossmatched blood Lab results may be
More informationSysmex CS-2500 Hemostasis System Unrestricted Siemens Healthcare Diagnostics Inc All rights reserved.
Excel with Confidence Sysmex CS-2500 Hemostasis System Unrestricted Siemens Healthcare Diagnostics Inc. 2015 All rights reserved. General Lab Challenges Test Volume Financial Performance Accuracy Reliability
More informationCoagulation Laboratory: Methods, Standards & Cost Effective Testing Part 1
Coagulation Laboratory: Methods, Standards & Cost Effective Testing Part 1 Donna D. Castellone, MS, MT (ASCP) SH Clinical Project Manager Hematology and Hemostasis Siemens Healthcare Diagnostics Disclosures
More informationNote: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.
Created Revised Reviewed Approved Lupus Insensitive aptt on the ACL TOP HEM 4.15.1 7/13/2012 4/11/2013 4/11/2013 4/11/2013 I. PRINCIPLE The activated partial thromboplastin time is a global screening procedure
More informationPlease note that the uses described in the following page(s) have not been approved or cleared by FDA, with respect to the described assay or test.
Please note that the uses described in the following page(s) have not been approved or cleared by FDA, with respect to the described assay or test. In the US, the product is intended For Research Use Only.
More informationApheresis Anticoagulant Removal. Oluwatoyosi Onwuemene, MD MS May 6th, 2017
Apheresis Anticoagulant Removal Oluwatoyosi Onwuemene, MD MS May 6th, 2017 Talk Outline Case presentation Factors associated with drug removal TPE s effects on hematologic parameters Anticoagulant properties
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON THE CLINICAL INVESTIGATION OF RECOMBINANT FACTOR VIII AND IX PRODUCTS
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 19 July 2007 CPMP/BPWG/1561/99 rev.1 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON THE
More informationCoagulation in perspective: Blood management. Objectives
Coagulation in perspective: Blood management Julie Wegner, PhD jawrbl@gmail.com Objectives To gain a basic understanding of the following: 1. Coagulation components and processes Why patients bleed. 2.
More informationLaboratory Aspects of recombinant porcine FVIII and extended half life concentrates
Laboratory Aspects of recombinant porcine FVIII and extended half life concentrates Rajiv K. Pruthi, M.B.B.S Co-Director, Special Coagulation Laboratory & Director, Mayo Comprehensive Hemophilia Center
More informationSpecial Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:
Special Coagulation - APC Resistance DiaPharma Group, Inc. Customer Service: 1.800.526.5224 Technical Support:1.800.447.3846 www.diapharma.com 1 Review of Hemostasis Overview Pathways of coagulation, anticoagulation,
More informationDEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK
DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK 11794-8205 COAGULATION COMPETENCY EVALUATION FORM STUDENT NAME:
More informationEffect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values
Coagulation and Transfusion Medicine / DIRECT THROMBIN INHIBITOR EFFECT ON INR Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values Robert C.
More informationFactor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate
Factor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate Application for retention on the WHO Model List From: Plasma Protein Therapeutics Association (PPTA) 1. Summary
More informationHuman Protein Process Sciences, Lille, France 2. Shabrawishi Hospital Blood Bank, Cairo, Egypt 3. University of Saskatoon, Canada
1 Human Protein Process Sciences, Lille, France 2 Shabrawishi Hospital Blood Bank, Cairo, Egypt 3 University of Saskatoon, Canada Why such a concept? Non-virally inactivated plasma components are still
More informationLonger acting/extended Half Life Products: Laboratory Monitoring
Longer acting/extended Half Life Products: Laboratory Monitoring Steve Kitchen Lead Clinical scientist Sheffield Haemophilia Centre & UK NEQAS Blood Coagulation Declaration of Interests -1 Speaker/ consultancy
More informationThese handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.
These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. If you would like the 1 slide per page handouts, please ask
More informationAssayMax Human Antithrombin III ELISA Kit
AssayMax Human Antithrombin III ELISA Kit Catalog # EA3302-1 Introduction The serine-protease-inhibitor antithrombin III (AT III), the most important natural inhibitor of thrombin activity, has been shown
More informationCategory Storage Shelf Life Additional Criteria
CE Update [blood banking/transfusion medicine] Blood Components for Hemostasis Jun Teruya, MD, DSc, and Glenn Ramsey, MD From the Department of Pathology, Northwestern University Medical School, Chicago.
More informationSession 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 1 of 4 Session 1 Topics Review of coagulation and the vascular phase of hemostasis Unfractionated heparin Low molecular
More informationMyBioSource.com. Human VEGF ELISA Kit
Human VEGF ELISA Kit Catalog No.: MBS355343 Size: 96T Range: 31.2 pg/ml-2000 pg/ml (human serum, plasma, body fluids) 15.6 pg/ml-1000 pg/ml (cell culture supernates) Sensitivity < 1 pg/ml Storage and Expiration:
More informationPROTHROMBIN TIME WHY USE LOW ISI (HIGH SENSITIVITY)
PROTHROMBIN TIME WHY USE LOW ISI (HIGH SENSITIVITY) PROTHROMBIN TIME DEFINITION The Prothrombin time is the functional determination of the extrinsic coagulation pathway. It is a widely used laboratory
More information2 Thomas G. DeLoughery
Tests of Hemostasis and Thrombosis 2 Thomas G. DeLoughery A routine laboratory test once well-established is often slavishly adhered to, with little further thought about how it originated, why it is done
More informationThe Coagulation Workup In The Office Setting
CAA Conference alm Springs 2012 The Coagulation Workup In The Office Setting CAA Conference alm Springs, October 2012 Robert Miller, A-C Henoch-Schoenlein urpura 1 CAA Conference alm Springs 2012 2 CAA
More informationIntroduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO
Introduction Hemostasis: Tourniquet Test & Bleeding Time Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Hemostasis A series of reactions that function to stop bleeding, maintaining
More informationAT Reduction Corrects Thrombin Generation in Samples From Hemophilia A & B Patients With Inhibitors
AT Reduction Corrects Thrombin Generation in Samples From Hemophilia A & B Patients With Inhibitors Gili Kenet, Tami Livnat, Emma Fosbury, Pratima Chowdary, Alfica Sehgal, Akin Akinc, Benny Sorensen 1
More informationYour Analyte ELISA Kit Instruction
NovaTeinBio FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC PURPOSES Your Analyte ELISA Kit Instruction Intended use The kit is used to detect the level of Your analyte in cell culture, serum blood plasma and
More informationHuman Plasmin Activity Assay ELISA Kit
Human Plasmin Activity Assay ELISA Kit Catalog No. CSI12527A 1 x 96 tests CSI12527B 5 x 96 tests Intended Use: Background: Assay Principle: Reagents Provided: This human plasmin activity assay is for the
More informationResidual Serum Thrombin
Residual Serum Thrombin Activity Murray Weiner N RECENT YEARS a remarkable number of blood and tissue components have been found to play a role in the formation of thrombin, the enzyme ultimately responsible
More informationFactor VIII Antibody Screen assay
INSTRUCTIONS FOR USE Factor VIII Antibody Screen assay REF F8S IVD TABLE OF CONTENTS INTENDED USE... 2 SUMMARY AND EXPLANATION... 2 PRINCIPLE OF THE PROCEDURE... 2 REAGENTS... 2 PRECAUTIONS... 3 CAUTION...
More informationHuman Factor IX (FIX)
Human Factor IX (FIX) ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO USA 63301 T: +1 (636) 447-9175 F: +1 (636) 395-7419 www.assaypro.com Emergo Europe Molenstraat 15 2513 BH The Hague
More informationCommon Inherited Bleeding Disorders
CAA 2015 Annual Conference Common Inherited Bleeding Disorders Bob Miller, A October 8, 2015 VWF has two jobs Loosely bound to protect FVIII and tether to site of injury All other coagulation factors also
More informationGuideline on the clinical investigation of recombinant and human plasma-derived factor VIII products
1 2 3 12 October 2017 EMA/CHMP/BPWP/144533/2009 rev. 2 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Guideline on the clinical investigation of recombinant and human plasma-derived factor
More informationHEMOCHRON. Whole Blood Coagulation Systems
HEMOCHRON Whole Blood Coagulation Systems Activated Partial Thromboplastin Time (APTT) Cuvette Correlation Protocol for HEMOCHRON Microcoagulation Instruments MSIG: 49 10/06 Dear Medical Professional:
More informationHuman VEGF-C ELISA. For the precise measurement of VEGF-C in human serum, plasma, body fluids, tissue homogenate or cell culture supernates.
Product information User s Manual Human VEGF-C ELISA For the precise measurement of VEGF-C in human serum, plasma, body fluids, tissue homogenate or cell culture supernates. BE69217 Storage: 96 2-8 C RUO
More informationEvaluation of the Bleeding Patient
Evaluation of the Bleeding Patient Screening Tests Rong He, MD Special Coagulation Laboratory, Division of Hematopathology 2015 MFMER slide-1 DISCLOSURE Relevant Financial Relationship(s) None 2015 MFMER
More informationCharacterization of the Recombinant Human Factor VIII Expressed in the Milk of Transgenic Swine. William Anderson Hodges
Characterization of the Recombinant Human Factor VIII Expressed in the Milk of Transgenic Swine William Anderson Hodges Thesis submitted to the faculty of the Virginia Polytechnic Institute and State University
More informationCelluvative. Cellular Therapies Redefined. A portfolio of products and services brought to you by: Saving lives today. Improving life tomorrow.
Cellular Therapies Redefined A portfolio of products and services brought to you by: Saving lives today. Improving life tomorrow. cell u va tive / sel-yoo-vā-tiv/ noun 1. a partnership between BloodCenter
More informationVALIDATION GUIDE FOR CHROMOGENIC ASSAY FOR ACTIZYME Anti-FIIa
VALIDATION GUIDE FOR CHROMOGENIC ASSAY FOR ACTIZYME Anti-FIIa Chromogenic assay for testing heparins (UFH, LMWH and Enoxaparin) in purified systems by measurement of FIIa Inhibition, in compliance with
More informationComparison of Several Activated Partial Thromboplastin Time Methods
Comparison of Several Activated Partial Thromboplastin Time Methods ROBERT J. MOWN, M.D., AND DOROTHY WILLOUGHBY, B.S., M.T. (ASCP) Department of Pathology, Harbor General Hospital, UCLA School of Medicine,
More informationHUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT
HUMAN CTGF ELISA KIT Page 1 HUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT PURCHASE INFORMATION: FOR THE QUANTITATIVE DETERMINATION OF HUMAN CTGF CONCENTRATIONS IN SERUM AND PLASMA ELISA NAME Catalog
More informationHaemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis
Haemostasis Haemostasis The function of haemostasis is: to prevent blood loss from injured vessels to stop bleeding to prevent thrombosis Haemostasis blood endothelium basement membrane subendothelium
More informationHuman Protein Z ELISA Kit
AssayMax Human Protein Z ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationHuman AGP1/alpha 1 acid glycoprotein PicoKine ELISA Kit
BOSTER BIOLOGICAL TECHNOLOGY 3942 B Valley Ave, Pleasanton, CA 94566 Phone: 888-466-3604 Fax: 925-215-2184 Email: boster@bosterbio.com Web: www.bosterbio.com Human AGP1/alpha 1 acid glycoprotein PicoKine
More information2015 Catalogue Coagulation
2015 Catalogue Coagulation 1 CONTENTS Reagents TriniCLOT TM Routine Reagents PT 4 aptt 4 Fibrinogen 5 Thrombin Time 5 Factor Deficient Plasmas 5 Solutions 5 TriniLIA TM D-Dimer TriniLIA TM D-Dimer 6 TriniCLOT
More informationSAMPLE. Determination of Coagulation Factor Activities Using the One-Stage Clotting Assay
2nd Edition H48 Determination of Coagulation Factor Activities Using the One-Stage Clotting Assay This guideline provides recommendations regarding the proper collection and handling of specimens, reagents,
More informationUP AND COMING ANTICOAGULANTS AND HEMOSTASIS AGENTS
UP AND COMING ANTICOAGULANTS AND HEMOSTASIS AGENTS Jeffrey I Weitz, MD, FRCP(C), FACP Professor of Medicine and Biochemistry McMaster University Canada Research Chair in Thrombosis Heart & Stroke Foundation/
More informationUpon completion of the Clinical Hematology rotation, the MLS student will be able to:
Clinical Performance Objectives in Clinical Hematology Department of Medical and Research Technology University of Maryland School of Medicine Spring 2015 Upon completion of the Clinical Hematology rotation,
More informationHuman BDNF ELISA. For the precise measurement of BDNF in human serum, plasma, body fluids, tissue homogenate or cell culture supernates.
Product information User s Manual Human BDNF ELISA For the precise measurement of BDNF in human serum, plasma, body fluids, tissue homogenate or cell culture supernates. BE69099 Storage: 96 2-8 C RUO For
More informationAssayMax Human Factor XI ELISA Kit
AssayMax Human Factor XI ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationThe Clotting Times. Editorial. CLOT-ED A Tree (of Knowledge) Grows Up Issue 1 Year 2010
20-07-2010 Issue 1 Year 2010 ECAT Foundation P.O. Box 30 2300 AA Leiden The Netherlands Website: www.ecat.nl E-mail: info@ecat.nl Phone: +31.(0)71.5181793 Fax: +31.(0)71.5181330 Editor in Chief: P. ter
More informationMarcia L. Zucker, Ph.D. ZIVD LLC
Marcia L. Zucker, Ph.D. ZIVD LLC 1 Monitoring hemostasis Bleeding Clotting 2 Picture courtesy of Helena Laboratories 3 Extrinsic Pathway Monitor with ACT / aptt WARFARIN Monitor with PT Common Pathway
More informationWith Stago, discover an outstanding Routine range
In Haemostasis, There s routine... and then there s Routine With Stago, discover an outstanding Routine range An optimal Routine range for guaranteed satisfaction 1 Comprehensive range Stago s extensive
More informationReview Article. Abstract. Introduction
Review Article Guidelines on the laboratory diagnosis of congenital bleeding disorders in Pakistan Munira Borhany, Tahir Shamsi, Bushra Moiz, Khalid Hasan, Khalid Zafar Hashmi, Muhammad Ayyub, Nadir Ali,
More informationHUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT
PAGE 1 HUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT FOR THE QUANTITATIVE DETERMINATION OF HUMAN CTGF CONCENTRATIONS IN SERUM AND PLASMA ALWAYS REFER TO LOT SPECIFIC PROTCOL PROVIDED WITH EACH
More informationHUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT
PAGE 1 HUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT FOR THE QUANTITATIVE DETERMINATION OF HUMAN CTGF CONCENTRATIONS IN SERUM AND PLASMA PURCHASE INFORMATION: ELISA NAME Catalog No. Lot No. Formulation
More informationHuman IL-6 ELISA. For the precise measurement of IL-6 in human serum, plasma, body fluids, tissue homogenate or cell culture supernates.
Product information User s Manual Human IL-6 ELISA For the precise measurement of IL-6 in human serum, plasma, body fluids, tissue homogenate or cell culture supernates. BE69157 Storage: 96 2-8 C RUO For
More informationPre-Analytic Issues in Laboratory Medicine
Pre-Analytic Issues in Laboratory Medicine Daniel J. Fink, MD, MPH Director, Core Laboratory New York Presbyterian hospital Columbia University Medical Center October 3, 2006 Learning Objectives Pre-Analytic
More informationStore samples to be assayed within 24 hours at 2-8 C. For long-term storage, aliquot and freeze samples at -20 C. Avoid repeated freeze-thaw cycles.
Human Retinol Binding Protein 4, RBP4 ELISA Kit Preparation Plate Washing Discard the solution in the plate without touching the side walls. Blot the plate onto paper towels or other absorbent material.
More informationHuman TGF-beta1 ELISA
K-ASSAY Human TGF-beta1 ELISA For the quantitative determination of TGF-beta1 in human cell culture supernates, serum, plasma (EDTA) and urine Cat. No. KT-1471 For Research Use Only. Not for diagnostic
More informationROTEM Basic Interpretation Guide
ROTEM Basic Interpretation Guide Parameter: Clotting Time CT - Clotting Time (seconds) The time from the start of the test until first significant levels of a clot are detected. This measurement is initiated
More informationA specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa Lu G, Deguzman FR, Hollenbach SJ, et al. Department of Biology, Portola Pharmaceuticals Inc.,
More informationPorcine IgM (Immunoglobulin M) ELISA Kit
Porcine IgM (Immunoglobulin M) ELISA Kit Catalogue No: EP0085 Size: 48T/96T Reactivity: Porcine Detection Range: 0.156-10ng/ml Sensitivity:
More informationHuman IL-1 Alpha PicoKine ELISA Kit
BOSTER BIOLOGICAL TECHNOLOGY 3942 B Valley Ave, Pleasanton, CA 94566 Phone: 888-466-3604 Fax: 925-215-2184 Email: boster@bosterbio.com Web: www.bosterbio.com Human IL-1 Alpha PicoKine ELISA Kit Catalog
More informationHUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT
HUMAN CTGF ELISA KIT PAGE 1 HUMAN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) ELISA KIT PURCHASE INFORMATION: ELISA NAME HUMAN CTGF ELISA FOR THE QUANTITATIVE DETERMINATION OF HUMAN CTGF CONCENTRATIONS IN SERUM
More informationPERFUSION TECHNOLOFISTS OF GREATER CHICAGO, INC. POLICY AND PROCEDURE MEDTRONIC HEMOTEC ACTIVATED CLOTTING TIME (ACT) OPERATING PROCEDURE
DATE OF REVISION Page 1 of 13 (ACT) OPERATING PROCEDURE PRINCIPLE: The ACT test is a definitive test used to monitor the anticoagulant effect of heparin. It measures the clotting time of fresh whole blood
More informationInfluence of Residual Platelet Count on Routine Coagulation, Factor VIII, and Factor IX Testing in Postfreeze-Thaw Samples
834 Influence of Residual Platelet Count on Routine Coagulation, Factor VIII, and Factor IX Testing in Postfreeze-Thaw Samples Giuseppe Lippi, MD 1 Rossana Rossi, PhD 1 Luigi Ippolito, MD 1 Valentina Zobbi,
More informationStago Newsletter. Diagnostica Stago Pty Ltd 651 Doncaster Road Doncaster, Vic Phone:
Diagnostica Stago Pty Ltd 651 Doncaster Road Doncaster, Vic 3108 Phone: +61 3 9840 5555 E-mail: info@stago.com Stago Newsletter V O L U M E 1, I S S U E 2 A U G U S T 2 0 1 0 I N S I D E T H I S I S S
More informationHUMAN ENDOTHELIAL- CELL SPECIFIC MOLECULE- 1 (ESM-1) ELISA KIT
PAGE 1 HUMAN ENDOTHELIAL- CELL SPECIFIC MOLECULE- 1 (ESM-1) ELISA KIT FOR THE QUANTITATIVE DETERMINATION OF HUMAN ESM-1 CONCENTRATIONS IN SERUM AND EDTA PLASMA ALWAYS REFER TO LOT SPECIFIC PROTCOL PROVIDED
More informationCustomer Service. For further product information, technical advice, prices or to place an order contact. Phone:
Customer Service For further product information, technical advice, prices or to place an order contact Phone: + 43 1 86373-0 Fax: + 43 1 86373-44 Sales: sales@technoclone.com Product Support: products@technoclone.com
More informationSEED Coagulation. Sysmex Educational Enhancement and Development April 2014
SEED Coagulation Sysmex Educational Enhancement and Development April 2014 The Thrombin Time Test and Reptilase Test what is their role in coagulation testing? Baseline screening tests of coagulation The
More informationAssayMax Human Factor V ELISA Kit
AssayMax Human Factor V ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationAssayMax Human Fibrinogen ELISA Kit
AssayMax Human Fibrinogen ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationMOUSE ENDOTHELIAL- CELL SPECIFIC MOLECULE- 1 (ESM-1) ELISA KIT
PAGE 1 MOUSE ENDOTHELIAL- CELL SPECIFIC MOLECULE- 1 (ESM-1) ELISA KIT FOR THE QUANTITATIVE DETERMINATION OF MOUSE ESM-1 CONCENTRATIONS IN CELL CULTURE SUPERNATES, SERUM AND EDTA PLASMA ALWAYS REFER TO
More informationAPOB (Human) ELISA Kit
APOB (Human) ELISA Kit Catalog Number KA1028 96 assays Version: 17 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationSuppl. Materials and methods
Suppl. Materials and methods Amino acid sequences of recombinant Fc-fusion forms of the EGF1,2, EGF1, and EGF2 of FIX and FX Recombinant Fc-fusion form of the first and second epidermal growth factor (EGF)-like
More informationManagement of Hemophilia under Limited Resources
Management of Hemophilia under Limited Resources Ampaiwan Chuansumrit, M.D. ISTH Advanced Training Course International Hemophilia Training Center-Bangkok Faculty of Medicine Ramathibodi Hospital, Mahidol
More informationPotentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition Bhavya S. Doshi 1, Bagirath Gangadharan 2, Christopher B. Doering
More informationRat Fibrinogen ELISA Kit
AssayMax TM Rat Fibrinogen ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationSandwich High Sensitivity ELISA kit for Quantitative Detection of Human VEGF in cell culture supernates, serum, and plasma (heparin, EDTA, citrate).
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Phone: 858.458.0866 Fax: 858.458.0833 Email: techline@genwaybio.com http://www.genwaybio.com Human VEGF ELISA Kit Catalog Number: Size: GWB-ZZK029
More informationHuman alpha-1-antitrypsin ELISA Kit
AssayMax Human alpha-1-antitrypsin ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or
More informationIG Production and Safety
IG Production and Safety Platelet Disorder Support Association July 20, 2013 Mary Gustafson, Vice President, PPTA Global Regulatory Policy Presentation Outline Introduction - PPTA Plasma Collection Final
More informationMouse Factor XII Total ELISA Kit
Mouse Factor XII Total ELISA Kit Catalog No: IMFXIIKT-TOT Lot No: SAMPLE INTENDED USE This mouse coagulation Factor XII antigen assay is intended for the quantitative determination of total Factor XII
More informationHow to Maximize Resources, Optimize Quality and Minimize Costs in the Coagulation Laboratory- by the Laboratory Whisperer
How to Maximize Resources, Optimize Quality and Minimize Costs in the Coagulation Laboratory- by the Laboratory Whisperer Donna D Castellone, MS, MT(ASCP)SH QA Manager, Specialty Testing Supervisor, Special
More informationHuman IgG Antigen ELISA Kit
Human IgG Antigen ELISA Kit Catalog No: IHUIGGKT Lot No: SAMPLE INTENDED USE This human immunoglobulin G antigen assay is intended for the quantitative determination of total human IgG antigen in serum,
More informationIMMUNOPRECIPITATION (IP)
1 IMMUNOPRECIPITATION (IP) Overview and Technical Tips 2 CONTENTS 3 7 8 9 12 13 17 18 19 20 Introduction Factors Influencing IP General Protocol Modifications Of IP Protocols Troubleshooting Contact Us
More informationAssayMax Human Transferrin ELISA Kit
AssayMax Human Transferrin ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationHuman IGF1R/Igf1 Receptor PicoKine ELISA Kit
BOSTER BIOLOGICAL TECHNOLOGY 3942 B Valley Ave, Pleasanton, CA 94566 Phone: 888-466-3604 Fax: 925-215-2184 Email: boster@bosterbio.com Web: www.bosterbio.com Human IGF1R/Igf1 Receptor PicoKine ELISA Kit
More informationActivated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring. Biochemical Basis for Discordance
Coagulation and Transfusion Medicine / vs Level Discrepancies ctivated Partial Thromboplastin Time and Measurements in Heparin Monitoring iochemical asis for Discordance Clifford M. Takemoto, MD, 1 Michael.
More information